Scholars Central

Mini reviewPublished 31 Jan 2024

IL-14: A Promising Frontier in Immune Therapy

Authors: Nicolas Middleton

Department of Immunology, Vrije Universiteit Brussel, Belgium

Journal of Cytokine Biology

Volume 9 · Issue 1 · Pages 01–02

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Interleukin-14 (IL-14), originally characterized for its involvement in B cell biology, has emerged as a multifaceted cytokine with profound immunomodulatory properties. Its dualistic nature, exerting both pro-inflammatory and immunoregulatory effects, positions IL-14 as a promising frontier in immune therapy. This abstract explores the diverse functions of IL-14 and its therapeutic implications in cancer immunotherapy and autoimmune diseases. By elucidating the intricate mechanisms underlying IL-14-mediated immune regulation and developing targeted therapeutic strategies, we aim to harness its potential for advancing precision medicine and improving patient outcomes in diverse disease settings.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cytokine Biology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cytokine Biology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Nicolas Middleton”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels